Indication
Staphylococcus saprophyticus urinary tract infection
A *Staphylococcus saprophyticus* urinary tract infection is a bacterial infection of the urinary system caused by *Staphylococcus saprophyticus*, a novobiocin-resistant, coagulase-negative Gram-positive coccus. Read more about Staphylococcus saprophyticus urinary tract infection
165 drugs 93 manufacturers
Drugs that treat it
Common Staphylococcus saprophyticus urinary tract infection therapies.
CIPROFLOXACIN-D5W (ciprofloxacin lactate/dextrose 5 % in water)
BLUJEPA (gepotidacin mesylate)
LEVOFLOXACIN
NITROFURANTOIN MONO-MACRO (nitrofurantoin monohydrate/macrocrystals)
MACROBID (nitrofurantoin monohydrate/macrocrystals)
PIVYA (pivmecillinam HCl)
LEVOFLOXACIN
CIPROFLOXACIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA *Staphylococcus saprophyticus* urinary tract infection is a bacterial infection of the urinary system caused by *Staphylococcus saprophyticus*, a novobiocin-resistant, coagulase-negative Gram-positive coccus.
It primarily manifests as an acute, uncomplicated lower urinary tract infection (cystitis) in immunocompetent, sexually active young adult females, representing one of the leading etiologies of community-acquired cystitis in this demographic.
Pathophysiologically, the organism adheres to uroepithelial cells and produces urease, eliciting mucosal inflammation characterized clinically by dysuria, urinary frequency, urgency, suprapubic discomfort, and commonly pyuria or hematuria.
Less frequently, the pathogen can ascend to cause upper urinary tract complications such as acute pyelonephritis.
- nih.gov
A *Staphylococcus saprophyticus* urinary tract infection is a bacterial infection of the urinary system caused by *Staphylococcus saprophyticus*, a novobiocin-resistant, coagulase-negative Gram-positive coccus It primarily manifests as an acute, uncomplicated lower urinary tract infection (cystitis) in immunocompetent, sexually active young adult females, representing one of the leading etiologies of community-acquired cystitis in this demographic Pathophysiologically, the organism adheres to ur...
- nih.gov
It primarily manifests as an acute, uncomplicated lower urinary tract infection (cystitis) in immunocompetent, sexually active young adult females, representing one of the leading etiologies of community-acquired cystitis in this demographic Less frequently, the pathogen can ascend to cause upper urinary tract complications such as acute pyelonephritis
- nih.gov
It primarily manifests as an acute, uncomplicated lower urinary tract infection (cystitis) in immunocompetent, sexually active young adult females, representing one of the leading etiologies of community-acquired cystitis in this demographic
- cdc.gov
It primarily manifests as an acute, uncomplicated lower urinary tract infection (cystitis) in immunocompetent, sexually active young adult females, representing one of the leading etiologies of community-acquired cystitis in this demographic
- canada.ca
Pathophysiologically, the organism adheres to uroepithelial cells and produces urease, eliciting mucosal inflammation characterized clinically by dysuria, urinary frequency, urgency, suprapubic discomfort, and commonly pyuria or hematuria
- nih.gov
Pathophysiologically, the organism adheres to uroepithelial cells and produces urease, eliciting mucosal inflammation characterized clinically by dysuria, urinary frequency, urgency, suprapubic discomfort, and commonly pyuria or hematuria
- nih.gov
Less frequently, the pathogen can ascend to cause upper urinary tract complications such as acute pyelonephritis
Personalize your experience
Follow Staphylococcus saprophyticus urinary tract infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.